TruthArchive.ai - Related Video Feed

Some antiparasitic drugs like mabendazole and ivermectin have shown effectiveness against certain cancers. Combining these drugs with others has led to the disappearance of solid tumors in some patients. It's not a single drug but a combination approach that yields results.

Ivermectin may have potential in fighting cancer by stopping the growth or killing certain cancer cells. Research suggests it could be effective against various cancers like breast, prostate, stomach, and others by inducing natural cell death. It is even used alongside chemotherapy for breast cancer. Consult your doctor before using Ivermectin. For more cancer-fighting tips, visit ehealthandu.com.

Ivermectin, a 62-year-old drug, has received a Nobel Prize for its unique properties. It has been found to block 8 pathways to cancer, making it a valuable repurposed drug in cancer treatment.

I have three friends who had stage 4 cancer, and now they are cancer-free. They used treatments like Ivermectin, Fenbendazole, and methylene blue, which was originally a textile dye but has shown significant benefits for mitochondria. It's surprising to see effective treatments being overlooked, raising questions about the medical industry's priorities. Why are cures that aren't profitable often ignored or demonized? This situation highlights a failure in our medical institutions to promote genuinely effective solutions.

Parasites and cancer have been overlooked, with numerous studies on Ivermectin and cancer conducted by the NIH. Videos from doctors worldwide show that cancer cells resemble parasite egg sacks under a microscope. A chiropractor named Brian Artis discussed this with a parasitologist friend, who revealed that oncologists rarely make the connection between cancer and parasites, despite it being a common topic in parasitology circles. The reason for this silence is likely the fear of losing funding.

Ivermectin, known for its use in treating COVID-19, has also shown promise in treating aggressive cancers such as glioblastomas, stage 4 breast and colon cancers, pancreatic cancers, gallbladder cancers, renal cancers, and melanomas. Research suggests that higher doses of Ivermectin can halt the growth and metastasis of these cancer cells, as well as induce apoptosis and autophagy to kill them. It is worth considering Ivermectin as a potential treatment for these aggressive cancers, in addition to its effectiveness against viral outbreaks.

Ivermectin, a 62-year-old drug, has been found to have multiple uses. It received a Nobel Prize for its unique abilities, including blocking 8 pathways to cancer. As a result, Ivermectin is now being repurposed as a treatment for cancer patients.

I have three friends who had stage 4 cancer, and now they are cancer-free. They used treatments like Ivermectin, Fenbendazole, and methylene blue, which was originally a fabric dye but is now known to have significant effects on mitochondria. It's surprising to discover that many effective treatments are overlooked or demonized, raising questions about the motives behind our medical institutions. Why are these cures not promoted when they are not profitable?

There is a growing concern about the connection between parasites and cancer, which has been largely ignored. The NIH has conducted numerous studies on Ivermectin and its potential in treating cancer. Doctors worldwide are now sharing videos that show the similarities between cancer cells and parasite egg sacs under a microscope. A chiropractor named Brian Artis discussed this with a 40-year Egyptian endologist, who was surprised that oncologists had never made this association. It seems that cytologists often discuss the link between cancer and parasites, but oncologists remain silent, possibly due to fear of losing funding.

I have three friends who had stage 4 cancer, and now they’re cancer-free. They took Ivermectin, Fenbendazole, and Methylene Blue, which has surprising benefits for mitochondria. It’s concerning how effective treatments are often ignored for profit. I got COVID and received remdesivir, which caused severe issues, while a friend died. There’s a troubling trend of prioritizing profit over lives in healthcare. Monoclonal antibodies were restricted to promote vaccines, which raises ethical questions. Mel Gibson and others are starting to speak out against these issues, highlighting the dangers of certain treatments and the need for awareness. We must recognize the importance of sharing knowledge and supporting those who fight against these injustices.

Two patients with advanced cancer saw improvements after taking Ivermectin. The first patient, with stage 4 prostate cancer, experienced a decrease in PSA levels and improvement in symptoms. The second patient, diagnosed with esophageal tumors, saw the tumors disappear after taking Ivermectin. Both patients showed positive outcomes from using Ivermectin for their cancer treatment.

A man diagnosed with terminal colon cancer saw significant improvement after taking Ivermectin alongside chemotherapy. His CEA levels dropped rapidly, and the number of tumors in his liver decreased from 25 to 3. Despite eventually succumbing to liver failure, his wife credits Ivermectin for extending his life beyond the initial prognosis. This anecdotal story highlights the potential benefits of Ivermectin in cancer therapy.

I am presenting a case series of three patients whose cancers went into remission after taking the antiparasitic drug fenbendazole, as detailed in a paper published in Clinical Oncology Case Reports. Fenbendazole is a veterinary medicine that interferes with microtubule formation during cell division, which may inhibit cancer cell proliferation. This suggests it could be a safe and effective option for cancer treatment. There is an urgent need for drug regulators to consider repurposing fenbendazole for human use, especially since other safe treatments have been approved quickly. Further research is necessary to establish its role as a chemotherapy option. The paper indicates that these three patients experienced significant improvement in their cancer conditions. For more details, refer to the full paper.

Ivermectin, a 62-year-old drug, has been recognized with a Nobel Prize for its unique properties. It effectively blocks 8 pathways to cancer, making it a valuable repurposed drug for cancer patients.

Ivermectin is taken seriously by oncology in the UK and has shown anti-cancer activity, along with other drugs like thalidomide, CBD, and artemisinins. Ivermectin has multiple anti-cancer mechanisms and is given to millions worldwide, reportedly saving two million people a year from blindness. Mebendazole and febendazole, similar anti-parasitics, also have crossover links. Anecdotal evidence suggests these are used when conventional therapies fail. Ivermectin has few side effects at doses several times higher than normal, while mebendazole may cause liver toxicity, so intermittent use is recommended. A concoction of both is used to extend cancer treatment efficacy. Studies are needed to determine if there is real benefit, identify which people respond, determine the best management protocol and dose, and create a database of when ivermectin works. Oncology is using very high doses compared to normal. Intermittent use may be better than constant exposure. Formal studies are needed to determine if intermittent ivermectin at normal doses with mebendazole/febendazole is better than continuous high-dose ivermectin.

Ivermectin, known for its use in treating COVID-19, has also shown promise in treating aggressive cancers like glioblastomas, stage 4 breast and colon cancers, pancreatic cancers, gallbladder cancers, renal cancers, and melanomas. Research suggests that higher doses of Ivermectin can halt the growth and metastasis of these cancer cells, inducing apoptosis and autophagy to kill them. It is worth considering Ivermectin as a potential treatment for these turbo cancers, in addition to its effectiveness against viral outbreaks.

Ivermectin, a 62-year-old drug, has been found to have multiple uses. It received a Nobel Prize for its unique abilities, including blocking eight pathways to cancer. As a result, Ivermectin is now being repurposed as a treatment for cancer patients.

Thirty years, forty years. They'll look back at chemotherapy as a barbaric and kind of caveman like thinking of destroying the entire body to treat a cancer. Know, we gotta get away from this. We gotta move towards targeted approaches and even towards natural compounds, like medicinal mushrooms—cordyceps, turkey tail mushroom—these have shown lots of promise. But also ivermectin and fenbendazole are now gaining national attention as possible cancer treatments, with positive anecdotal reports of remission after taking these products. A recent study—a systematic review of ivermectin in cancer—found not only is it completely safe if people are undergoing conventional treatment, but it does show potent anti-tumor effects in the test tube via 10 mechanisms. And so, we gotta go to natural compounds. Forty years from now, I hope we’re not still administering chemotherapy as the main form of treatment.

Chemotherapy is claimed to be a hoax and scam by big pharma to profit from suffering people. It allegedly prolongs life by only two to three months and may reduce life expectancy for some cancers like gastric cancer. Chemotherapy is also said to help cancer spread and activate cancer stem cells. Chemotherapy drugs can cost patients over $100,000 a year, leading to financial problems for 50-60% of patients. Ivermectin combined with mebendazole or fenbendazole is suggested as a potentially effective first-line therapy for cancer. Testing over-the-counter medications and cheap prescriptions is recommended as well.

Ivermectin, a Nobel Prize-winning anti-parasitic drug, has been vilified. Merck, who held the patent until 1996, claims it doesn't work for COVID-19. However, Merck has a 50/50 partnership with Moderna on mRNA cancer vaccines. Because Merck will make billions on mRNA cancer vaccines, they have no interest in investigating ivermectin for cancer. There is evidence that high-dose ivermectin is effective in treating many types of cancers.

I have three friends who had stage 4 cancer, and now they are cancer-free. They used treatments like ivermectin, fenbendazole, and methylene blue, which was originally a textile dye but is now found to have significant effects on mitochondria. It's surprising how many effective treatments are overlooked or demonized, often due to profit motives. Many beneficial substances, such as vitamin D, K2, magnesium, zinc, and quercetin, are not promoted because they lack patent protection and cannot be controlled by pharmaceutical companies.

The speaker focuses on treating stage four cancer patients, often with late diagnoses. They use ivermectin combined with fenbendazole or mebendazole, both antiparasitics, even in early-stage breast cancer cases before surgery. The speaker claims that stage four cancers, including pancreatic, ovarian, and melanoma, have responded, with some patients becoming cancer-free. Tumors reportedly shrink significantly within months when patients take ivermectin and mebendazole before surgery. The speaker notes that ivermectin and fenbendazole are inexpensive, off-patent drugs, but customs in British Columbia and Mississauga are allegedly confiscating packages. A published paper supports the use of ivermectin and fenbendazole in cancer treatment. The speaker treated a friend of Mel Gibson, who then shared the story on Joe Rogan's podcast. Ivermectin is described as a chemo and radio sensitizer. The speaker faced backlash from a pancreatic cancer support group for sharing a patient's story. The speaker claims to have patients in hospice who are now cancer-free and one patient who was offered medical assistance in dying but is now cancer-free. The speaker recounts a case where a patient with terminal melanoma and liver failure stabilized and improved with ivermectin and fenbendazole. Oncologists are portrayed as limited to expensive, profitable treatments.

- It acts on these signaling pathways called PAC-one and ACT and MTOR and WNT pathways, these are pathways that are involved in tumor proliferation, tumor growth. - ivermectin inhibits multiple of these pathways that inhibit tumor growth, tumor proliferation, leads to cell cycle arrest, and it also inhibits metastases and the ability of the tumors to create blood vessels for themselves. - Then ivermectin also acts on cancer stem cells. It inhibits cancer stem cells. - They're involved in metastases, and they're involved in cancer recurrence. - cancer stem cells tend to be resistant to chemo. And then your cancer comes roaring back because these cancer stem cells start proliferating again. - So it inhibits cancer stem cells, very important. - Ivermectin also reverses multi drug resistance. So if you develop resistance to certain chemotherapy, Ivermectin will reverse it and Ivermectin acts in combination with chemo or radiation therapy. - Guzzo 2002 safety study: "the conclusion was that ivermectin was generally well tolerated with no indication of CNS toxicity." - up to two milligrams per kilogram per day.

Ivermectin, the controversial anti-parasitic drug, has shown potential in stopping the growth or killing certain cancer cells. Research suggests that it may be effective against various types of cancer, including breast, prostate, stomach, colon, liver, lung, kidney, and leukemia. Ivermectin induces apoptosis, or natural cell death, in cancer cells. It is even being used alongside chemotherapy for breast cancer. However, it is important to consult with your doctor before considering Ivermectin for any purpose. For more information on fighting cancer, you can watch a lecture by Dr. Shintani at ehealthandu.com. This is Dr. Chintani, a board-certified MD and nutritionist trained at Harvard, signing off for your health.

But I think there's you know, what's beautiful now because so many doctors are stepping up and seeing something and talking about something, I'm not saying that's the right thing. 'Is ivermectin improving cancer? Certainly some doctors have seen it.' 'So is that the way we is it improving for everybody? What is it in ivermectin that improves the microbiome of certain people and not in others? What is it in ivermectin that helps certain cancers and not others? Right? So we really need to be better to say, okay, look, I'm courageous enough to add ivermectin to my protocol of the chemo or the bio or the immunotherapy that I'm giving or maybe I don't.' 'And maybe at least I look at the microbiome. I look at the microbiome on what is believed right now, you know, a a good look at it.'